A multicenter, open-label, phase III study of Abcertin in Gaucher disease.
Lee BH, Abdalla AF, Choi JH, Beshlawy AE, Kim GH, Heo SH, Megahed AMH, Elsayed MAL, Barakat TEM, Eid KMAE, El-Tagui MH, Mahmoud MMH, Fateen E, Park JY, Yoo HW.
Lee BH, et al. Among authors: yoo hw.
Medicine (Baltimore). 2017 Nov;96(45):e8492. doi: 10.1097/MD.0000000000008492.
Medicine (Baltimore). 2017.
PMID: 29137040
Free PMC article.
Clinical Trial.